Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 21% ± 6% | |
epithelial cell | 6 studies | 27% ± 6% | |
retinal rod cell | 4 studies | 17% ± 2% | |
GABAergic neuron | 4 studies | 36% ± 13% | |
glutamatergic neuron | 4 studies | 45% ± 15% | |
oligodendrocyte | 4 studies | 21% ± 2% | |
fibroblast | 3 studies | 22% ± 3% | |
rod bipolar cell | 3 studies | 18% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 5% | |
dendritic cell | 3 studies | 22% ± 7% | |
transit amplifying cell | 3 studies | 22% ± 6% | |
interneuron | 3 studies | 37% ± 17% | |
neuron | 3 studies | 23% ± 4% | |
astrocyte | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1608.54 | 180 / 180 | 100% | 13.65 | 430 / 430 |
esophagus | 100% | 2164.25 | 1444 / 1445 | 100% | 22.33 | 183 / 183 |
breast | 100% | 2962.11 | 459 / 459 | 100% | 24.63 | 1117 / 1118 |
intestine | 100% | 2422.01 | 966 / 966 | 100% | 17.51 | 526 / 527 |
uterus | 100% | 2141.74 | 170 / 170 | 100% | 18.38 | 458 / 459 |
lung | 100% | 2123.24 | 576 / 578 | 100% | 19.82 | 1155 / 1155 |
brain | 100% | 2662.32 | 2632 / 2642 | 100% | 17.39 | 705 / 705 |
stomach | 100% | 2178.48 | 358 / 359 | 100% | 17.67 | 285 / 286 |
liver | 100% | 2974.65 | 226 / 226 | 99% | 12.86 | 403 / 406 |
bladder | 100% | 2357.81 | 21 / 21 | 99% | 16.27 | 500 / 504 |
prostate | 100% | 1811.26 | 245 / 245 | 99% | 15.30 | 498 / 502 |
thymus | 100% | 2459.98 | 653 / 653 | 99% | 13.79 | 600 / 605 |
pancreas | 99% | 1415.28 | 326 / 328 | 99% | 12.78 | 177 / 178 |
kidney | 100% | 2122.01 | 89 / 89 | 99% | 13.98 | 888 / 901 |
skin | 100% | 2565.66 | 1809 / 1809 | 98% | 19.43 | 463 / 472 |
adrenal gland | 100% | 3444.06 | 258 / 258 | 97% | 13.69 | 224 / 230 |
adipose | 100% | 2978.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.12 | 29 / 29 |
muscle | 100% | 4932.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1840.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.54 | 1 / 1 |
blood vessel | 100% | 2161.44 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 2588.29 | 827 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 8.09 | 73 / 80 |
peripheral blood | 48% | 1261.82 | 445 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070125 | Biological process | mitochondrial translational elongation |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005525 | Molecular function | GTP binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0003746 | Molecular function | translation elongation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | GFM1 |
Protein name | Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1) G elongation factor mitochondrial 1 isoform 3 Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) G elongation factor mitochondrial 1 |
Synonyms | EFG EFG1 GFM |
Description | FUNCTION: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. . FUNCTION: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. . FUNCTION: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. . |
Accessions | ENST00000264263.9 [Q96RP9-2] A0A0S2Z5W5 F8WAU4 C9IZ01 E5KND5 E5KND7 ENST00000478576.5 C9JA25 Q96RP9 ENST00000486715.6 [Q96RP9-1] ENST00000478254.5 ENST00000472383.1 ENST00000464732.1 H7C5M4 |